申请人:Merrell Pharmaceuticals Inc.
公开号:US05684017A1
公开(公告)日:1997-11-04
The present invention relates to novel benzenesulfonylimine derivatives and their use as inhibitors of Interleukin-1 (IL-1) action. Such inhibitors are useful in the treatment of various disease states as disclosed herein including: rheumatoid arthritis, multiple sclerosis, diabetes mellitus, atherosclerosis, septic shock and pulmonary fibrosis.
本发明涉及新型苯磺酰亚胺衍生物及其作为白细胞介素-1(IL-1)作用抑制剂的用途。这些抑制剂在治疗包括风湿性关节炎、多发性硬化症、糖尿病、动脉粥样硬化、脓毒性休克和肺纤维化在内的各种疾病状态中是有用的。